[HTML][HTML] PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance

M Rose, JT Burgess, K O'Byrne, DJ Richard… - Frontiers in cell and …, 2020 - frontiersin.org
… of the mechanisms behind sensitization of tumors to PARP … mechanisms of action of
PARPi, biomarkers of the tumor … combination therapies and mechanisms of tumor resistance. …

Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance

MA Fuertes, C Alonso, JM Pérez - Chemical reviews, 2003 - ACS Publications
… all of the above-mentioned resistance mechanisms. However, after more … resistance
mechanism to cisplatin might be related with hyperactivation of telomerase and inability of the tumor

The role and mechanisms of action of microRNAs in cancer drug resistance

W Si, J Shen, H Zheng, W Fan - Clinical epigenetics, 2019 - Springer
… in drug resistance, and their targets in different tumor cells. … in drug-resistant tumor cells, we
will analyze the mechanisms of … mechanisms of miRNAs in regulating tumor drug resistance. …

Overview of tumor cell chemoresistance mechanisms

L Gatti, F Zunino - Chemosensitivity: Volume II: In VIVO Models, Imaging …, 2005 - Springer
… This chapter presents an overview of the drug resistance mechanisms. … of human tumors.
Therapeutic approaches aimed to overcome a single resistance mechanism have been …

Herceptin: mechanisms of action and resistance

R Nahta, FJ Esteva - Cancer letters, 2006 - Elsevier
… This review describes mechanisms by which Herceptin inhibits cell growth in breast cancers
resistance within 1 year [48], [62]. Elucidating the molecular mechanisms by which tumors

[PDF][PDF] Cellular mechanisms of multidrug resistance of tumor cells

AA Stavrovskaya - Biochemistry c/c of Biokhimiia, 2000 - researchgate.net
… by many other causes besides tumor cell alterations; it may be … this paper only the mechanisms
of drug resistance of cells will … diversity of the mechanisms of cellular resistance to drugs. …

Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects

AM Florea, D Büsselberg - Cancers, 2011 - mdpi.com
… CDDP has clinical benefit for several types of solid tumors; however, the efficiency of
CDDP is often accompanied by toxic side effects and tumor resistance, which in turn leads to …

[HTML][HTML] Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity

Y Xu, MA Villalona-Calero - Annals of oncology, 2002 - Elsevier
… provides insights into the basis of irinotecan toxicity and tumor resistance [10]. Irinotecan is a
unique … The metabolism and mechanism of action of irinotecan are summarized in Figure 1. …

[PDF][PDF] Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

C Dumontet, BI Sikic - Journal of Clinical Oncology, 1999 - Citeseer
resistant tumors in patients treated with tubulin-binding agents. Clinical trials aiming to
sensitize MDR-positive tumors … the possible nonMDR mechanisms of resistance to tubulin-binding …

Trastuzumab emtansine: mechanisms of action and drug resistance

M Barok, H Joensuu, J Isola - Breast cancer research, 2014 - Springer
… It has several mechanisms of action consisting of the anti-tumor effects of trastuzumab
and those of DM1, a cytotoxic anti-microtubule agent released within the target cells upon …